These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39373828)

  • 1. Using high-repeatable radiomic features improves the cross-institutional generalization of prognostic model in esophageal squamous cell cancer receiving definitive chemoradiotherapy.
    Gong J; Wang Q; Li J; Yang Z; Zhang J; Teng X; Sun H; Cai J; Zhao L
    Insights Imaging; 2024 Oct; 15(1):239. PubMed ID: 39373828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomic feature repeatability and its impact on prognostic model generalizability: A multi-institutional study on nasopharyngeal carcinoma patients.
    Zhang J; Lam SK; Teng X; Ma Z; Han X; Zhang Y; Cheung AL; Chau TC; Ng SC; Lee FK; Au KH; Yip CW; Lee VH; Han Y; Cai J
    Radiother Oncol; 2023 Jun; 183():109578. PubMed ID: 36822357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
    Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
    Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy.
    Nakamoto T; Yamashita H; Jinnouchi H; Nawa K; Imae T; Takenaka S; Aoki A; Ohta T; Ozaki S; Nozawa Y; Nakagawa K
    Phys Med; 2024 Jan; 117():103182. PubMed ID: 38086310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal acquisition repeatability of MRI radiomics features: An ACR MRI phantom study on two MRI scanners using a 3D T1W TSE sequence.
    Wong OL; Yuan J; Zhou Y; Yu SK; Cheung KY
    Med Phys; 2021 Mar; 48(3):1239-1249. PubMed ID: 33370474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model.
    Kong J; Zhu S; Shi G; Liu Z; Zhang J; Ren J
    Front Oncol; 2021; 11():739933. PubMed ID: 34631575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of reproducible radiomic features from on-board volumetric images: A multi-institutional phantom study.
    Adachi T; Nakamura M; Iramina H; Matsumoto K; Ishihara Y; Tachibana H; Kurokawa S; Cho S; Tanaka K; Fukumoto K; Nishiyama T; Kito S; Mizowaki T
    Med Phys; 2023 Sep; 50(9):5585-5596. PubMed ID: 36932977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 9. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
    Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
    BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Repeatability and Multiscanner Reproducibility of MRI Radiomics Features in Patients With Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Study.
    Wennmann M; Bauer F; Klein A; Chmelik J; Grözinger M; Rotkopf LT; Neher P; Gnirs R; Kurz FT; Nonnenmacher T; Sauer S; Weinhold N; Goldschmidt H; Kleesiek J; Bonekamp D; Weber TF; Delorme S; Maier-Hein K; Schlemmer HP; Götz M
    Invest Radiol; 2023 Apr; 58(4):253-264. PubMed ID: 36165988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Zhang D; Gao Y; Duan J; Wang L; Li L; Yuan S
    Insights Imaging; 2024 Mar; 15(1):87. PubMed ID: 38523188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeatability of
    Pfaehler E; Beukinga RJ; de Jong JR; Slart RHJA; Slump CH; Dierckx RAJO; Boellaard R
    Med Phys; 2019 Feb; 46(2):665-678. PubMed ID: 30506687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Li L; Liu N; Hou W; Dong Y; Yang F; Zhu S; Li J; Yuan S
    Biomark Res; 2023 Apr; 11(1):44. PubMed ID: 37095586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeatability of radiomic features in magnetic resonance imaging of glioblastoma: Test-retest and image registration analyses.
    Shiri I; Hajianfar G; Sohrabi A; Abdollahi H; P Shayesteh S; Geramifar P; Zaidi H; Oveisi M; Rahmim A
    Med Phys; 2020 Sep; 47(9):4265-4280. PubMed ID: 32615647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer.
    Kawahara D; Nishioka R; Murakami Y; Emoto Y; Iwashita K; Sasaki R
    Eur J Surg Oncol; 2024 Jul; 50(7):108450. PubMed ID: 38843660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer.
    Delgadillo R; Spieler BO; Ford JC; Kwon D; Yang F; Studenski M; Padgett KR; Abramowitz MC; Dal Pra A; Stoyanova R; Pollack A; Dogan N
    Med Phys; 2021 May; 48(5):2386-2399. PubMed ID: 33598943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an [
    Takahashi N; Tanaka S; Umezawa R; Takanami K; Takeda K; Yamamoto T; Suzuki Y; Katsuta Y; Kadoya N; Jingu K
    Acta Oncol; 2023 Feb; 62(2):159-165. PubMed ID: 36794365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer
    Kolinger GD; García DV; Kramer GM; Frings V; Zwezerijnen GJC; Smit EF; de Langen AJ; Buvat I; Boellaard R
    J Nucl Med; 2022 Jun; 63(6):919-924. PubMed ID: 34933890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer.
    Li H; Chen XL; Liu H; Lu T; Li ZL
    Front Oncol; 2022; 12():1087882. PubMed ID: 36686763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.